{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:02:55Z","timestamp":1791018175490,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4470,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.fertnstert.2008.11.018","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T04:26:28Z","timestamp":1231561588000},"page":"1290-1298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells"],"prefix":"10.1016","volume":"93","author":[{"given":"Meagan M.","family":"Grudzien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Steven","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Arredondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert J.","family":"Belton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana A.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.11.018_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00003081-200106000-00023","article-title":"Medical treatment of uterine fibroids","volume":"44","author":"Chavez","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0149-2918(00)88309-5","article-title":"Hospitalization costs associated with leiomyoma","volume":"21","author":"Zhao","year":"1999","journal-title":"Clin Therap"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00003081-200106000-00019","article-title":"Identification of new therapies for leiomyomas: what in vitro studies can tell us","volume":"44","author":"Nowak","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signaling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib8","first-page":"F105","article-title":"TGF-beta receptor signaling","volume":"1333","author":"Derynck","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-beta signals","volume":"1","author":"Massague","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib10","series-title":"Molecular biology of the female reproductive system","first-page":"457","article-title":"Growth factor and cytokine expression in the endometrium","author":"Murphy","year":"1994"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/molehr\/3.3.233","article-title":"The expression of transforming growth factor-betas and TGF-beta receptor mRNA and protein and the effect of TGF-betas on human myometrial smooth muscle cells in vitro","volume":"3","author":"Tang","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib12","first-page":"913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta","volume":"86","author":"Lee","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-\u03b23 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<371::AID-DDR19>3.0.CO;2-R","article-title":"Halofuginone: from veterinary use to human therapy","volume":"50","author":"Pines","year":"2000","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-4165(93)90123-P","article-title":"Halofuginone: an inhibitor of collagen type I synthesis","volume":"1156","author":"Granot","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.0022-202x.2001.01690.x","article-title":"Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts","volume":"118","author":"McGaha","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.ATV.17.1.194","article-title":"Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone","volume":"17","author":"Nagler","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","article-title":"Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma","volume":"9","author":"Pines","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib19","doi-asserted-by":"crossref","first-page":"15167","DOI":"10.1074\/jbc.M309798200","article-title":"Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone","volume":"279","author":"Xavier","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1164\/ajrccm.154.4.8887611","article-title":"Reduction in pulmonary fibrosis in vivo by halofuginone","volume":"154","author":"Nagler","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pros.10059","article-title":"Growth inhibition of prostate cancer xenografts by halofuginone","volume":"51","author":"Gavish","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1189\/jlb.0705409","article-title":"Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells","volume":"80","author":"Leiba","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib23","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1159\/000093674","article-title":"Inhibition of rat renal fibroblast proliferation by halofuginone","volume":"104","author":"Haran","year":"2006","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib24","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ejca.2003.11.036","article-title":"Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone","volume":"40","author":"Nagler","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2003.08.007","article-title":"The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy","volume":"209","author":"Chegini","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib26","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1074\/jbc.M600030200","article-title":"Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB","volume":"281","author":"Popov","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1357-2725(97)00128-3","article-title":"Transforming growth factor-beta (TGF-beta)","volume":"30","author":"Clark","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib28","first-page":"602","article-title":"[Histological and biochemical studies of collagen in human uterine leiomyomas]","volume":"60","author":"Fujita","year":"1985","journal-title":"Hokkaido Igaku Zasshi"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib29","first-page":"900","article-title":"Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle","volume":"79","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0962-8924(02)00007-7","article-title":"Extracellular matrix in vascular morphogenesis and disease: structure versus signal","volume":"13","author":"Brooke","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib31","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1073\/pnas.170290997","article-title":"Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1","volume":"97","author":"Henriet","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0092-8674(00)81801-2","article-title":"Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors","volume":"87","author":"Koyama","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.142.2.587","article-title":"Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo","volume":"142","author":"Pozzi","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib34","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/MCB.21.8.2906-2917.2001","article-title":"Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development","volume":"21","author":"Vogel","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/01.RES.0000022166.74073.F8","article-title":"Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression","volume":"90","author":"Hou","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1097-2765(00)80003-9","article-title":"The discoidin domain receptor tyrosine kinases are activated by collagen","volume":"1","author":"Vogel","year":"1997","journal-title":"Mol Cell"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/molehr\/gal018","article-title":"In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and leiomyoma smooth muscle cells","volume":"12","author":"Zaitseva","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/gcc.10240","article-title":"HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies","volume":"38","author":"Gross","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2008.11.018_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/molehr\/gah199","article-title":"Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferators-activated receptor ligand, pioglitazone","volume":"11","author":"Loy","year":"2005","journal-title":"Mol Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208045901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208045901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:37:42Z","timestamp":1758008262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208045901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0015028208045901"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.11.018","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}